Clinical Trial Update: A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis [Phase 2]

View source ↗

Summary

Phase II trial update for Flonoltinib maleate tablets in intermediate-high-risk myelofibrosis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Post-essential Thrombocythemia Myelofibrosis
• Post-polycythemia Vera Myelofibrosis

Drugs mentioned

• Flonoltinib Maleate Tablet (flonoltinib maleate)

Snippet

Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd | Conditions: MF,PMF,PPV-MF,PET-MF | Phase 2 | Status: RECRUITING